We said we would keep tracking. Here is where things stand today.
Since our last publication, we have continued reaching out to key decision-makers within the cosmetics industry regarding the presence of endocrine disruptors in consumer products.
Once again, we are met with silence.
Silence is not neutral.
Silence is a position.
It reflects:
– A lack of engagement with documented public health concerns
– A refusal to provide clarity to consumers
– A delay in addressing questions that deserve urgent attention
Today, we are extending the list of individuals we have contacted — professionals in positions where action is possible, and expected:
– Mickael Poletti, Research and Development Director at Hermes Parfums & Beauté
– David Petit, Packaging Development Director at Hermes
– Axel Dumas, CEO of Hermes
– Antoine Arnault, Image and Environment Director LVMH
– Jean Baptiste Voisin, Cheief Strategy Officier LVMH
– Stephane Bianchi, Group Managing Director LVMH
These are individuals with influence, oversight, and the capacity to initiate internal review, demand transparency, and contribute to safer practices.
We are not making accusations.
We are documenting a lack of response.
And that absence matters.
Consumers have the right to:
– Understand what is in the products they use
– Receive clear and transparent communication
– Trust that health considerations are taken seriously
We remain open to dialogue.
We remain ready to publish any response received.
Until then, we will continue to document who engages — and who does not.
Because accountability is not optional.
And public health cannot wait indefinitely.
More updates to follow.
#FightAgainstEndocrineDisruptors #PublicHealth #Transparency #SafeCosmetics #Accountability